These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6349538)

  • 21. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
    Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of lentinan for advanced prostate carcinoma].
    Tari K; Satake I; Nakagomi K; Ozawa K; Oowada F; Higashi Y; Negishi T; Yamada T; Saito H; Yoshida K
    Hinyokika Kiyo; 1994 Feb; 40(2):119-23. PubMed ID: 8128920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
    Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
    Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
    Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
    Akimoto M; Nishihira T; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticancer immunotherapy with perorally effective lentinan].
    Hamuro J
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1209-15. PubMed ID: 16121931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].
    Wada T; Nishide T; Hatayama K; Chang SW; Tatsuta M; Yasutomi M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2509-12. PubMed ID: 3113339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
    Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
    Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
    Shimizu K; Watanabe S; Watanabe S; Matsuda K; Suga T; Nakazawa S; Shiratori K
    Hepatogastroenterology; 2009; 56(89):240-4. PubMed ID: 19453066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
    Fujimoto K; Tomonaga M; Goto S
    Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer.
    Yoshino S; Watanabe S; Imano M; Suga T; Nakazawa S; Hazama S; Oka M
    Hepatogastroenterology; 2010; 57(97):172-7. PubMed ID: 20422897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
    Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
    Nishihira T; Akimoto M; Mori S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
    Kagawa R; Nakayama N; Yamaguchi T; Sakata S; Tada M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1989-94. PubMed ID: 12465402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
    Kitamura S; Ohtani T; Kurihara M; Kosaki G; Akazawa S; Sasaki T; Takahashi H; Nakano S; Tokunaga K
    Gan To Kagaku Ryoho; 1995 May; 22(6):765-75. PubMed ID: 7755384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
    Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
    Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.